申请人:Pharmuka Laboratoires
公开号:US04613607A1
公开(公告)日:1986-09-23
Antiarhythmic medicaments containing, as active substance, a compound of the formula: ##STR1## in which n is 1 or 2, X and Y are fixed in positions 5, 6, 7 or 8 on the quinoline cycle and each represents a hydrogen atom or an alkoxy group having 1 to 3 carbons, R is a hydrogen atom or an alkyl group having 1 to 4 carbons, cycloalkyl having 3 to 8 carbons, phenyl or phenyl substituted by alkoxy having 1 to 4 carbons, R.sub.1 is a hydrogen atom or an alkyl group having 1 to 4 carbons or a phenylalkyl group of which the alkyl part has 1 to 3 carbons, R.sub.2 is a hydrogen atom, an alkyl group having 1 to 2 carbons or an alkenyl group having 2 to 4 carbons.
抗心律失常药物含有一种化合物作为活性物质,该化合物的结构式为:##STR1##其中n为1或2,X和Y在喹啉环上的位置为5、6、7或8,每个都代表一个氢原子或具有1至3个碳的烷氧基团,R为一个氢原子或具有1至4个碳的烷基团、具有3至8个碳的环烷基、苯基或被1至4个碳的烷氧基取代的苯基,R.sub.1为一个氢原子或具有1至4个碳的烷基团或其烷基部分具有1至3个碳的苯基烷基团,R.sub.2为一个氢原子、具有1至2个碳的烷基团或具有2至4个碳的烯基团。